HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.

Abstract
Type 2 diabetes (T2D) is characterized by lack of insulin, insulin resistance and high blood sugar. However, the underlying mechanisms of insulin resistance during T2D development remains unclear. As the most common mRNAs modification, N6-Methyladenosine (m6A) is involved in many of pathological processes in aging disease. However, it remains unclear whether m6A is involved in T2D development and what is the regulatory mechanism. This study is aimed to illustrate the roles of m6A and its methyltransferase METTL3 in the regulation of blood glucose homeostasis and insulin sensitivity. The results showed that m6A methylated RNA level and its N6-methyladenosine methylase METTL3 were consistently up-regulated in the liver tissues from patients with T2D. Moreover, both m6A methylated RNA and METTL3 levels showed positive correlation with HOMA-IR and negative correlation with HOMA-β. The m6A methylated RNA and METTL3 levels were also up-regulated in mouse with 16 weeks high-fat diet (HFD), compared with mice fed a standard chow diet (CD). Hepatocyte-specific knockout of METTL3 in mice fed a HFD improved insulin sensitivity and decreased fatty acid synthesis. Furthermore, mechanism analysis demonstrates that METTL3 silence decreased the m6A methylated and total mRNA level of Fatty acid synthase (Fasn), subsequently inhibited fatty acid metabolism. Adeno-associated virus mediated Fasn overexpression in METTL3 knockout mice abrogates the improved insulin sensitivity and decreased fatty acid synthesis. Collectively, these results reveal that RNA N6-methyladenosine methylase METTL3 inhibits hepatic insulin sensitivity via N6-methylation of Fasn mRNA and promoting fatty acid metabolism.
AuthorsWei Xie, Lei Lei Ma, Yue Qing Xu, Bao Hua Wang, Sai Mei Li
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 518 Issue 1 Pg. 120-126 (10 08 2019) ISSN: 1090-2104 [Electronic] United States
PMID31405565 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Chemical References
  • Fatty Acids
  • RNA, Messenger
  • N-methyladenosine
  • Methyltransferases
  • Mettl3 protein, mouse
  • METTL3 protein, human
  • FASN protein, human
  • Fasn protein, mouse
  • Fatty Acid Synthase, Type I
  • Glucose
  • Adenosine
Topics
  • Adenosine (analogs & derivatives, metabolism)
  • Animals
  • Dependovirus (metabolism)
  • Diabetes Mellitus, Type 2 (metabolism)
  • Disease Models, Animal
  • Fatty Acid Synthase, Type I (metabolism)
  • Fatty Acids (metabolism)
  • Gene Deletion
  • Glucose (metabolism)
  • Hepatocytes (metabolism)
  • Homeostasis
  • Humans
  • Insulin Resistance
  • Liver (metabolism)
  • Methylation
  • Methyltransferases (metabolism)
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Obesity (genetics, pathology)
  • RNA, Messenger (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: